119 related articles for article (PubMed ID: 24619665)
1. Single-step antigen loading and maturation of dendritic cells through mRNA electroporation of a tumor-associated antigen and a TriMix of costimulatory molecules.
Benteyn D; Van Nuffel AM; Wilgenhof S; Bonehill A
Methods Mol Biol; 2014; 1139():3-15. PubMed ID: 24619665
[TBL] [Abstract][Full Text] [Related]
2. Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients.
Bonehill A; Van Nuffel AM; Corthals J; Tuyaerts S; Heirman C; François V; Colau D; van der Bruggen P; Neyns B; Thielemans K
Clin Cancer Res; 2009 May; 15(10):3366-75. PubMed ID: 19417017
[TBL] [Abstract][Full Text] [Related]
3. mRNA Electroporation of Dendritic Cells with WT1, Survivin, and TriMix (a Mixture of caTLR4, CD40L, and CD70).
Coosemans A; Tuyaerts S; Morias K; Corthals J; Heirman C; Thielemans K; Van Gool SW; Vergote I; Amant F
Methods Mol Biol; 2016; 1428():277-83. PubMed ID: 27236806
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccination with an autologous mRNA electroporated dendritic cell vaccine in patients with advanced melanoma.
Wilgenhof S; Van Nuffel AM; Corthals J; Heirman C; Tuyaerts S; Benteyn D; De Coninck A; Van Riet I; Verfaillie G; Vandeloo J; Bonehill A; Thielemans K; Neyns B
J Immunother; 2011 Jun; 34(5):448-56. PubMed ID: 21577140
[TBL] [Abstract][Full Text] [Related]
5. Modulation of regulatory T cell function by monocyte-derived dendritic cells matured through electroporation with mRNA encoding CD40 ligand, constitutively active TLR4, and CD70.
Pen JJ; De Keersmaecker B; Maenhout SK; Van Nuffel AM; Heirman C; Corthals J; Escors D; Bonehill A; Thielemans K; Breckpot K; Aerts JL
J Immunol; 2013 Aug; 191(4):1976-83. PubMed ID: 23842750
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of cancer with dendritic cells loaded with tumor antigens and activated through mRNA electroporation.
Van Nuffel AM; Corthals J; Neyns B; Heirman C; Thielemans K; Bonehill A
Methods Mol Biol; 2010; 629():405-52. PubMed ID: 20387165
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of TriMix and antigen mRNA-based antitumor therapy.
Van Lint S; Goyvaerts C; Maenhout S; Goethals L; Disy A; Benteyn D; Pen J; Bonehill A; Heirman C; Breckpot K; Thielemans K
Cancer Res; 2012 Apr; 72(7):1661-71. PubMed ID: 22337996
[TBL] [Abstract][Full Text] [Related]
8. Intravenous and intradermal TriMix-dendritic cell therapy results in a broad T-cell response and durable tumor response in a chemorefractory stage IV-M1c melanoma patient.
Van Nuffel AM; Benteyn D; Wilgenhof S; Corthals J; Heirman C; Neyns B; Thielemans K; Bonehill A
Cancer Immunol Immunother; 2012 Jul; 61(7):1033-43. PubMed ID: 22159452
[TBL] [Abstract][Full Text] [Related]
9. Cytokine maturation followed by CD40L mRNA electroporation results in a clinically relevant dendritic cell product capable of inducing a potent proinflammatory CTL response.
Calderhead DM; DeBenedette MA; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
J Immunother; 2008 Oct; 31(8):731-41. PubMed ID: 18779746
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the T-cell stimulatory capacity of human dendritic cells by co-electroporation with CD40L, CD70 and constitutively active TLR4 encoding mRNA.
Bonehill A; Tuyaerts S; Van Nuffel AM; Heirman C; Bos TJ; Fostier K; Neyns B; Thielemans K
Mol Ther; 2008 Jun; 16(6):1170-80. PubMed ID: 18431362
[TBL] [Abstract][Full Text] [Related]
11. Generation of antigen-presenting cells using cultured dendritic cells and amplified autologous tumor mRNA.
Minami K; Yamaguchi Y; Ohshita A; Kawabuchi Y; Ohta K; Hihara J; Toge T
Oncology; 2005; 69(5):399-407. PubMed ID: 16319511
[TBL] [Abstract][Full Text] [Related]
12. In situ expression of tumor antigens by messenger RNA-electroporated dendritic cells in lymph nodes of melanoma patients.
Schuurhuis DH; Verdijk P; Schreibelt G; Aarntzen EH; Scharenborg N; de Boer A; van de Rakt MW; Kerkhoff M; Gerritsen MJ; Eijckeler F; Bonenkamp JJ; Blokx W; van Krieken JH; Boerman OC; Oyen WJ; Punt CJ; Figdor CG; Adema GJ; de Vries IJ
Cancer Res; 2009 Apr; 69(7):2927-34. PubMed ID: 19318559
[TBL] [Abstract][Full Text] [Related]
13. Delivery of tumor-antigen-encoding mRNA into dendritic cells for vaccination.
Michiels A; Tuyaerts S; Bonehill A; Heirman C; Corthals J; Thielemans K
Methods Mol Biol; 2008; 423():155-63. PubMed ID: 18370196
[TBL] [Abstract][Full Text] [Related]
14. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
[TBL] [Abstract][Full Text] [Related]
15. Priming of a novel subset of CD28+ rapidly expanding high-avidity effector memory CTL by post maturation electroporation-CD40L dendritic cells is IL-12 dependent.
DeBenedette MA; Calderhead DM; Ketteringham H; Gamble AH; Horvatinovich JM; Tcherepanova IY; Nicolette CA; Healey DG
J Immunol; 2008 Oct; 181(8):5296-305. PubMed ID: 18832685
[TBL] [Abstract][Full Text] [Related]
16. Electroporation of dendritic cells with autologous total RNA from tumor material.
Milano F; Krishnadath KK
Methods Mol Biol; 2014; 1139():87-95. PubMed ID: 24619673
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases.
Jansen Y; Kruse V; Corthals J; Schats K; van Dam PJ; Seremet T; Heirman C; Brochez L; Kockx M; Thielemans K; Neyns B
Cancer Immunol Immunother; 2020 Dec; 69(12):2589-2598. PubMed ID: 32591862
[TBL] [Abstract][Full Text] [Related]
18. Induction of antigen-specific CD8+ cytotoxic T cells by dendritic cells co-electroporated with a dsRNA analogue and tumor antigen mRNA.
Michiels A; Breckpot K; Corthals J; Tuyaerts S; Bonehill A; Heirman C; Thielemans K; Aerts JL
Gene Ther; 2006 Jul; 13(13):1027-36. PubMed ID: 16511519
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral Delivery of TriMix mRNA Results in T-cell Activation by Cross-Presenting Dendritic Cells.
Van Lint S; Renmans D; Broos K; Goethals L; Maenhout S; Benteyn D; Goyvaerts C; Du Four S; Van der Jeught K; Bialkowski L; Flamand V; Heirman C; Thielemans K; Breckpot K
Cancer Immunol Res; 2016 Feb; 4(2):146-56. PubMed ID: 26659303
[TBL] [Abstract][Full Text] [Related]
20. TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma.
De Keersmaecker B; Claerhout S; Carrasco J; Bar I; Corthals J; Wilgenhof S; Neyns B; Thielemans K
J Immunother Cancer; 2020 Feb; 8(1):. PubMed ID: 32114500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]